Qrg Capital Management, Inc. Bio N Tech Se Transaction History
Qrg Capital Management, Inc.
- $9.64 Trillion
- Q1 2025
A detailed history of Qrg Capital Management, Inc. transactions in Bio N Tech Se stock. As of the latest transaction made, Qrg Capital Management, Inc. holds 2,347 shares of BNTX stock, worth $246,646. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,347
Previous 2,415
2.82%
Holding current value
$246,646
Previous $275 Million
22.34%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding BNTX
# of Institutions
341Shares Held
40MCall Options Held
1.43MPut Options Held
1.54M-
Baillie Gifford & CO8.16MShares$858 Million0.67% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.26MShares$448 Million1.71% of portfolio
-
Primecap Management CO Pasadena, CA4.05MShares$425 Million0.31% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$199 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$190 Million0.84% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $25.5B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...